版本:
中国

BRIEF-Navidea Biopharmaceuticals files for non timely 10-K

March 16 Navidea Biopharmaceuticals Inc

* Navidea biopharmaceuticals files for non timely 10-k - sec filing

* Navidea biopharmaceuticals inc - expects to report revenues for the year ended december 31, 2016 of $22.0 million compared to $13.2 million for 2015

* Navidea biopharmaceuticals inc - expects operating expenses for year ended december 31, 2016 to be about $21.9 million versus $30.0 million for 2015 Source text : bit.ly/2mwOvzg Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐